Immunology

Tech round up: June 2024

Best new tech this month

Predictive model for tumour-killing cells

Scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer immunotherapies.

Personalised vaccines: A pioneering new immunotherapy

A look at the international trial of the world’s first personalised mRNA cancer immunotherapy for melanoma and its potential translation to other cancers and diseases.

My lab: antibodymediated autoimmune neurology

A guided tour of the Oxford Autoimmune Neurology Diagnostic Laboratory.

Vaccine for highly fatal tropical disease

In a mouse study, UCLA researchers tested a vaccine against the bacterium that causes melioidosis and found it was highly protective against the disease.

Cancer and stress breakthrough

Stress hormones can trigger the formation of structures that make body tissues more susceptible to metastasis, research has found.

“TB vaccine shrinks mice cancer tumours”

A new study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumour burden and extended the survival of mice with liver cancer.

The evolution of cancer

Charlie Swanton outlines the work in cancer research that led to him being awarded a 2024 Louis-Jeantet Prize for translational medicine.

Vaccine effective in preventing typhoid fever

A single dose of the typhoid conjugate vaccine Typbar TCV provides lasting efficacy in preventing typhoid fever in children aged nine months to 12 years old, according to a new study.

Autoimmune diseases revisited: part 3

Is autoimmunity on the increase? Epidemiological evidence. Details of five autoimmune diseases are presented.

Taming the chaotic protein that fuels cancers

MYC is a protein that it is claimed is responsible for making the majority of human cancer cases worse.

Top